The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Transmission of MERS-Coronavirus in Household Contacts
Open accessAbstract
BACKGROUND: Strategies to contain the Middle East respiratory syndrome coronavirus (MERS-CoV) depend on knowledge of the rate of human-to-human transmission, including subclinical infections. A lack of serologic tools has hindered targeted studies of transmission. METHODS: We studied 26 index patients with MERS-CoV infection and their 280 household contacts. The median time from the onset of symptoms in index patients to the latest blood sampling in contact patients was 17.5 days (range, 5 to 216; mean, 34.4). Probable cases of secondary transmission were identified on the basis of reactivity in two reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assays with independent RNA extraction from throat swabs or reactivity on enzyme-linked immunosorbent assay against MERS-CoV S1 antigen, supported by reactivity on recombinant S-protein immunofluorescence and demonstration of neutralization of more than 50% of the infectious virus seed dose on plaque-reduction neutralization testing. RESULTS: Among the 280 household contacts of the 26 index patients, there were 12 probable cases of secondary transmission (4%; 95% confidence interval, 2 to 7). Of these cases, 7 were identified by means of RT-PCR, all in samples obtained within 14 days after the onset of symptoms in index patients, and 5 were identified by means of serologic analysis, all in samples obtained 13 days or more after symptom onset in index patients. Probable cases of secondary transmission occurred in 6 of 26 clusters (23%). Serologic results in contacts who were sampled 13 days or more after exposure were similar to overall study results for combined RT-PCR and serologic testing. CONCLUSIONS: The rate of secondary transmission among household contacts of patients with MERS-CoV infection has been approximately 5%. Our data provide insight into the rate of subclinical transmission of MERS-CoV in the home.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,735
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574
Self-citationDipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
Raj, V. S., Mou, H., Smits, S. L., Dekkers, D. H. W., Müller, M. A., Dijkman, R., Muth, D., Demmers, J. A. A., Zaki, A., Fouchier, R. A. M., et al. (2013) · Nature · doi:10.1038/nature12005 · Cited by 2,061
Self-citationHospital outbreak of Middle East respiratory syndrome coronavirus
Assiri, A., McGeer, A., Perl, T. M., Price, C. S., Al Rabeeah, A. A., Cummings, D. A. T., Alabdullatif, Z. N., Assad, M., Almulhim, A., Makhdoom, H., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1306742 · Cited by 1,196
Self-citationReusken, C. B., Haagmans, B. L., Müller, M. A., Gutierrez, C., Godeke, G.-J., Meyer, B., Muth, D., Raj, V. S., Vries, L. S.-D., Corman, V. M., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70164-6 · Cited by 734
Self-citationDetection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction
Corman, V. M., Eckerle, I., Bleicker, T., Zaki, A., Landt, O., Eschbach-Bludau, M., van Boheemen, S., Gopal, R., Ballhause, M., Bestebroer, T. M., et al. (2012) · Eurosurveillance · doi:10.2807/ese.17.39.20285-en · Cited by 561
Self-citationSerological assays for emerging coronaviruses: Challenges and pitfalls
Meyer, B., Drosten, C., & Müller, M. A. (2014) · Virus Research · doi:10.1016/j.virusres.2014.03.018 · Cited by 410
Self-citationDrosten, C., Seilmaier, M., Corman, V. M., Hartmann, W., Scheible, G., Sack, S., Guggemos, W., Kallies, R., Muth, D., Junglen, S., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70154-3 · Cited by 387
Self-citationBreban, R., Riou, J., & Fontanet, A. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61492-0 · Cited by 385
Human Infection with MERS Coronavirus after Exposure to Infected Camels, Saudi Arabia, 2013
Memish, Z. A., Cotten, M., Meyer, B., Watson, S. J., Alsahafi, A. J., Al Rabeeah, A. A., Corman, V. M., Sieberg, A., Makhdoom, H. Q., Assiri, A., et al. (2014) · Emerging Infectious Diseases · doi:10.3201/eid2006.140402 · Cited by 365
Self-citationAssays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections
Corman, V. M., Müller, M. A., Costabel, U., Timm, J., Binger, T., Meyer, B., Kreher, P., Lattwein, E., Eschbach-Bludau, M., Nitsche, A., et al. (2012) · Eurosurveillance · doi:10.2807/ese.17.49.20334-en · Cited by 360
Self-citationCauchemez, S., Fraser, C., Van Kerkhove, M. D., Donnelly, C. A., Riley, S., Rambaut, A., Enouf, V., van der Werf, S., & Ferguson, N. M. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70304-9 · Cited by 347
Antibodies against MERS Coronavirus in Dromedary Camels, Kenya, 1992–2013
Corman, V. M., Jores, J., Meyer, B., Younan, M., Liljander, A., Said, M. Y., Gluecks, I., Lattwein, E., Bosch, B.-J., Drexler, J. F., et al. (2014) · Emerging Infectious Diseases · doi:10.3201/eid2008.140596 · Cited by 312
Self-citationAntibodies against MERS Coronavirus in Dromedary Camels, United Arab Emirates, 2003 and 2013
Meyer, B., Müller, M. A., Corman, V. M., Reusken, C. B. E. M., Ritz, D., Godeke, G.-J., Lattwein, E., Kallies, S., Siemens, A., van Beek, J., et al. (2014) · Emerging Infectious Diseases · doi:10.3201/eid2004.131746 · Cited by 268
Self-citationSpread, Circulation, and Evolution of the Middle East Respiratory Syndrome Coronavirus
Cotten, M., Watson, S. J., Zumla, A. I., Makhdoom, H. Q., Palser, A. L., Ong, S. H., Al Rabeeah, A. A., Alhakeem, R. F., Assiri, A., Al-Tawfiq, J. A., et al. (2014) · mBio · doi:10.1128/mbio.01062-13 · Cited by 266
Self-citationMüller, M. A., Raj, V. S., Muth, D., Meyer, B., Kallies, S., Smits, S. L., Wollny, R., Bestebroer, T. M., Specht, S., Suliman, T., et al. (2012) · mBio · doi:10.1128/mbio.00515-12 · Cited by 209
Self-citationReusken, C. B., Ababneh, M., Raj, V. S., Meyer, B., Eljarah, A., Abutarbush, S., Godeke, G. J., Bestebroer, T. M., Zutt, I., Müller, M. A., et al. (2013) · Eurosurveillance · doi:10.2807/1560-7917.es2013.18.50.20662 · Cited by 199
Self-citationBuchholz, U., Müller, M. A., Nitsche, A., Sanewski, A., Wevering, N., Bauer-Balci, T., Bonin, F., Drosten, C., Schweiger, B., Wolff, T., et al. (2013) · Eurosurveillance · doi:10.2807/ese.18.08.20406-en · Cited by 166
Self-citationAburizaiza, A. S., Mattes, F. M., Azhar, E. I., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit589 · Cited by 95
Specific serology for emerging human coronaviruses by protein microarray
Reusken, C. B. E. M., Mou, H., Godeke, G.-J., van der Hoek, L., Meyer, B., Müller, M. A., Haagmans, B. L., de Sousa, R., Schuurman, N., Dittmer, U., et al. (2013) · Eurosurveillance · doi:10.2807/1560-7917.es2013.18.14.20441 · Cited by 89
Self-citationHo, H., Chang, M.-S., Wei, T., Hsieh, W.-S., Hung, C.-C., Yang, H.-M., & Lu, Y. (2006) · CHEST Journal · doi:10.1378/chest.129.1.95 · Cited by 24
Cited by
Virological assessment of hospitalized patients with COVID-2019
Wölfel, R., Corman, V. M., Guggemos, W., Seilmaier, M., Zange, S., Müller, M. A., Niemeyer, D., Jones, T. C., Vollmar, P., Rothe, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2196-x · Cited by 6,661
Self-citationThe trinity of COVID-19: immunity, inflammation and intervention
Tay, M. Z., Poh, C. M., Rénia, L., MacAry, P. A., & Ng, L. F. P. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0311-8 · Cited by 4,360
Antibody responses to SARS-CoV-2 in patients with COVID-19
Long, Q.-X., Liu, B.-Z., Deng, H.-J., Wu, G.-C., Deng, K., Chen, Y.-K., Liao, P., Qiu, J.-F., Lin, Y., Cai, X.-F., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0897-1 · Cited by 2,876
Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China
Wu, A., Peng, Y., Huang, B., Ding, X., Wang, X., Niu, P., Meng, J., Zhu, Z., Zhang, Z., Wang, J., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.02.001 · Cited by 2,361
Coronaviruses — drug discovery and therapeutic options
Zumla, A., Chan, J. F. W., Azhar, E. I., Hui, D. S. C., & Yuen, K.-Y. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.37 · Cited by 1,707
Self-citation
Metadata
- Authors
- Drosten, C., Meyer, B., Müller, M. A., Corman, V. M., Al-Masri, M., Hossain, R., Madani, H., Sieberg, A., Bosch, B. J., Lattwein, E., Alhakeem, R. F., Assiri, A. M., Hajomar, W., Albarrak, A. M., Al-Tawfiq, J. A., Zumla, A. I., & Memish, Z. A.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2014-08-28
- Volume
- 371
- Issue
- 9
- Pages
- 828-835
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2108756402
- Cited by
- 393
- References
- 21
- FWCI
- 27.26
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.